Search results
Results from the WOW.Com Content Network
Supporters of direct-to-consumer advertising argue that advertisements increase competition which leads to lower prescription drug prices and new development, citing, for instance, that between 1997 and 2001, spending on research and development in the U.S. increased 59% while spending on promoting drugs directly to patients increased 145%.
In fact, Rhode Island General Laws Section 21-28-3.23 prohibits manufacturers and wholesalers of prescription drugs from advertising them to the general public. Unfortunately, the director of the ...
False Claims Act, Prescription Drug Marketing Act: 2012 Amgen [11] $762 million Off-label promotion, kickbacks Aranesp: False Claims Act, FDCA 2010 GlaxoSmithKline [12] $750 million Poor manufacturing practices Kytril, Bactroban, Paxil CR, Avandamet: False Claims Act, FDCA 2005 Serono [13] $704 million Off-label promotion, kickbacks ...
If she had to take a name-brand drug instead, she says she'd need to pay $1,000-$1,200 a month. The compounded drug she takes only costs around a couple hundred, without insurance.
The United States federal government is aggressively pursuing criminal and civil cases against pharmaceutical companies and their employees for promoting off-label uses of prescription drugs. [4] Between 2003 and 2008, U.S. federal prosecutors and state attorneys general brought more than a dozen cases against drug manufacturers for off-label ...
Gabapentin is a prescription medication that was approved by the U.S. Food and Drug Administration in 1993 as a treatment for epilepsy. It works by binding to a type of calcium channel in nerve ...
The Commonwealth of Virginia had a statute which prohibited pharmacists from advertising prescription drug prices, providing that those who did would be guilty of "unprofessional conduct". [2] Drug prices varied throughout the state, as the District Court found. [1]
Bourla's argument is that prescription drug prices only account for a fraction of overall health care spending in the U.S. “The total cost of medicines to the health care system represents 12% ...